|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2023
vol. 125 abstract:
Case report
Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting
Aleksander Lamkowski
1
,
Martyna Kałużna
1
,
Tomasz Pabin
1
KLINIKA OCZNA 2023, 125, 1: 56-59
Online publish date: 2023/02/09
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Valsalva retinopathy is a rare disease in which the pressure in the eye increases, leading to the development of a pre-retinal hemorrhage. It frequently occurs in completely healthy patients and leads to sudden and painless vision loss. It may arise due to vomiting, coughing, constipation, pregnancy, childbirth, and intense physical or sexual activity. In this article, we describe the case of a young man who developed Valsalva retinopathy.
The development and progression of nuclear cataracts may be influenced by many factors such as the process of lens oxidation, the use of infusion fluids, light toxicity, duration of vitrectomy or the type of endotamponade. The key to preventing cataract formation after vitrectomy is still elusive.
keywords:
Leiden mutation, Valsalva retinopathy, Nd:Yag laser, preretinal hemorrhage, increased blood clotting |
|
POLSKI
